Supporting I–O combination therapy development with correlative assays & biomarker discovery

Immuno-Oncology Insights 2023; 4(4), 161–169

DOI: 10.18609/ioi.2023.021

Published: 15 May 2023
Ana Rosa Saez Ibanez, Samik Upadhaya

Abi Pinchbeck, Assistant Editor, Immuno-Oncology Insights, speaks to (pictured left to right) Ana Rosa Saez-Ibanez and Samik Upadhaya from the Cancer Research Institute, about their research in combination therapies across the I–O landscape and the importance of implementation of correlative assays in combination clinical trials.